COMPARISON OF EUROPEAN AND USA GUIDELINES FOR PREVENTION OF CORONARY-HEART-DISEASE

被引:10
|
作者
STEIN, Y
机构
[1] Lipid Research Laboratory, Department of Medicine, Hadassah University Hospital, Jerusalem
关键词
HYPERLIPIDEMIA; ATHEROSCLEROSIS; HDL; LDL; RISK FACTORS;
D O I
10.1016/0021-9150(94)05376-T
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper deals with the comparison of European and American guidelines for prevention of CHD, screening and management of hyperlipidemia. The revised EAS guidelines consist of 4 chapters: the scientific basis of CHD prevention; strategies for prevention of CHD; setting up a primary care system for CHD prevention, and the fourth focuses on clinical management with healthy diet, lifestyle and drug treatment of risk factors for CHD. The EAS guidelines emphasize that therapeutic decisions are based on the assessment of the global risk of CHD. In both EAS and American guidelines, optimal total plasma cholesterol and triglyceride target values recommended are < 200 mg/dl for both parameters. Both guidelines state that the initial approach to the treatment of hyperlipidemia should involve diet, increased physical activity, and weight reduction. If target levels are not achieved, the physician should determine whether drug therapy is appropriate. Conservative measures (diet and exercise) are recommended in particular for premenopausal women, elderly subjects and adolescents. There is complete agreement on the importance of secondary prevention of CHD.
引用
收藏
页码:S41 / S44
页数:4
相关论文
共 50 条
  • [41] LIPOPROTEIN-CHOLESTEROL IN CORONARY-HEART-DISEASE (CHD) PATIENTS WITH AND WITHOUT EXERCISE TRAINING
    BERG, A
    KEUL, J
    STIPPIG, J
    SCHAUB, F
    [J]. INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 1981, 4 (02) : 211 - 213
  • [42] Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey
    De Smedt, Delphine
    Annemans, Lieven
    De Backer, Guy
    Kotseva, Kornelia
    Ryden, Lars
    Wood, David
    Amouyel, Philippe
    Bruthans, Jan
    Cifkova, Renata
    De Sutter, Johan
    Dolzhenko, Marina
    Erglis, Andrejs
    Gotcheva, Nina
    Gyberg, Viveca
    Laucevicius, Aleksandras
    Lovic, Dragan
    Oganov, Rafael
    Pajak, Andrzej
    Pogosova, Nana
    Reiner, Zeljko
    Stagmo, Martin
    De Bacquer, Dirk
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 272 : 20 - 25
  • [43] APOE POLYMORPHISM AND PREDISPOSITION TO CORONARY-HEART-DISEASE IN YOUTHS OF DIFFERENT EUROPEAN POPULATIONS - THE EARS STUDY (VOL 14, PG 1617, 1994)
    TIRET, L
    DEKNIJFF, P
    MENZEL, HJ
    EHNHOLM, C
    NICAUD, V
    HAVEKES, LM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (02) : 298 - 298
  • [44] PREVENTION OF CORONARY HEART-DISEASE
    DAVIES, DF
    [J]. LANCET, 1974, 1 (7859): : 685 - 685
  • [45] CORONARY HEART-DISEASE PREVENTION
    ROSS, IRF
    [J]. JOURNAL OF THE ROYAL COLLEGE OF GENERAL PRACTITIONERS, 1988, 38 (317): : 569 - 569
  • [46] The future of coronary heart disease prevention
    Durrington, P. N.
    [J]. CLINICAL MEDICINE, 2007, 7 (05) : 525 - 525
  • [47] Secondary prevention in coronary heart disease
    Haq, IU
    Minnis, RC
    Jackson, PR
    Yeo, WW
    Ramsay, LE
    [J]. JOURNAL OF HUMAN NUTRITION AND DIETETICS, 1996, 9 (05) : 363 - 371
  • [48] PREVENTION OF CORONARY HEART-DISEASE
    BRADSHAW, JS
    [J]. LANCET, 1976, 1 (7965): : 912 - 913
  • [49] PREVENTION OF CORONARY HEART-DISEASE
    KAY, CR
    [J]. BRITISH MEDICAL JOURNAL, 1983, 287 (6398): : 1064 - 1065
  • [50] PREVENTION OF CORONARY HEART-DISEASE
    BARRETTCONNOR, E
    [J]. SAUDI MEDICAL JOURNAL, 1990, 11 (05) : 335 - 340